We are live on ! Find out more
TLP

Tri Locum Partners Portfolio holdings

AUM $713M
1-Year Est. Return 68.92%
This Fund
S&P 500
This Quarter Est. Return
+11.94%
1 Year Est. Return
+68.92%
3 Year Est. Return
+377.81%
5 Year Est. Return
+1,289.15%
10 Year Est. Return
–
AUM
$403M
AUM Growth
+$128M
Cap. Flow
+$111M
Cap. Flow %
27.45%
Top 10 Hldgs %
71.78%
Holding
84
New
19
Increased
11
Reduced
3
Closed
50

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$26.4M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$24.8M
3
BMY icon
Bristol-Myers Squibb
BMY
+$24.1M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$18.2M
5
NUAN
Nuance Communications, Inc.
NUAN
+$15.3M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$20.7M
2
VTRS icon
Viatris
VTRS
+$19.6M
3
LH icon
Labcorp
LH
+$11M
4
CCXI
ChemoCentryx, Inc.
CCXI
+$10.3M
5
ZLAB icon
Zai Lab
ZLAB
+$8.42M

Sector Composition

Rank Sector Weight
1 Healthcare 71.82%
2 Technology 3.61%
3 Industrials 0.52%
4 Communication Services 0%
5 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VZ icon
76
Verizon
VZ
$195B
– –
-5,437
Closed -$319K
ZLAB icon
77
Zai Lab
ZLAB
$2.36B
– –
-62,235
Closed -$8.42M
AXNX
78
DELISTED
Axonics, Inc. Common Stock
AXNX
– –
-64,378
Closed -$3.21M
CBAY
79
DELISTED
Cymabay Therapeutics
CBAY
– –
-62,000
Closed -$356K
ONCT
80
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
– –
-14,286
Closed -$1.4M
CCXI
81
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-166,077
Closed -$10.3M
KDMN
82
DELISTED
Kadmon Holdings, Inc.
KDMN
– –
-15,618
Closed -$65K
GWPH
83
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-40,159
Closed -$4.63M
BHVN
84
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-19,832
Closed -$1.7M
1 2 3
4

Similar funds

DCM
Defilade Capital Management Emeryville, California $712M AUM
AMPWP
Alvarez & Marsal Private Wealth Partners West Palm Beach, Florida $712M AUM
DCM
Dimension Capital Management Coral Gables, Florida $713M AUM 18.57% 1-Year Est. Return
PCS
Personal CFO Solutions Chester, New Jersey $712M AUM 25.3% 1-Year Est. Return
ACGDR
Atmos Capital Gestao de Recursos Leblon - Rio De Janeiro, Brazil $714M AUM 35.97% 1-Year Est. Return
GEA
Glen Eagle Advisors Kingston, New Jersey $714M AUM 18.87% 1-Year Est. Return
ECM
EagleClaw Capital Management Boston, Massachusetts $714M AUM 24.24% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return

Tri Locum Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Tri Locum Partners held 84 positions worth $403M, up 46% from $275M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Tri Locum Partners deployed $111M of net new capital in Q1 2021, opening 19 new positions and adding to 11 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 293,426 shares worth $27M.

By sector, the portfolio is most concentrated in Healthcare at 72% of assets, down from 93% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Walgreens Boots Alliance, an estimated $2.05M trimmed.

  • Tri Locum Partners's largest Q1 2021 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 293,426 shares worth $27M.
  • Tri Locum Partners added most to Regeneron Pharmaceuticals in Q1 2021, an estimated $26.4M increase.
  • Tri Locum Partners's biggest Q1 2021 reduction was Walgreens Boots Alliance, cutting an estimated $2.05M.
  • Tri Locum Partners fully exited AbbVie in Q1 2021, selling an estimated $20.7M.
  • Tri Locum Partners's ten largest holdings make up 72% of its $403M portfolio in Q1 2021.
  • Tri Locum Partners opened 19 new positions and closed 50 in Q1 2021.
  • Tri Locum Partners's portfolio value rose 46% quarter-over-quarter to $403M.

Based on Tri Locum Partners's 13F filing for Q1 2021, filed 17 May 2021.